<http://webisa.webdatacommons.org/234109696>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<wiley.com> .
<http://webisa.webdatacommons.org/234109696>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/432930305>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/234109696> .
<http://webisa.webdatacommons.org/prov/219583620>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/234109696> .
<http://webisa.webdatacommons.org/234109696>	<http://www.w3.org/ns/prov#value>	"However, this conclusion is an oversimplification of the risks and benefits and we would counter reason that any risk of major bleeding in a patient without a true PE, or at very low risk of recurrent VTE, is unacceptable.SSPE: what is the current clinical practice?Top of pageAbstractIntroductionSSPE: a new diagnosis?SSPE: a ???new??? increasingly encou" .